Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging

Stock Information for Champions Oncology Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Champions Oncology Inc.

Champions Oncology Reports Revenue of $15.2 Million
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
Champions Oncology Reports Record Annual Revenue of $59 Million
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Champions Oncology Reports Revenue of $16.6 Million
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.